vTv Therapeutics Inc.
VTVTNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $342.37M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $19.50$44.00
- Volume (live)
- -
- Avg. volume (3M)
- 34.19K
vTv Therapeutics (VTVT) Stock Price & Financial Analysis
vTv Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $25.95 - $27.49 |
|---|---|
| 52-Week High | $44.00 |
| 52-Week Low | $19.50 |
| Open | $27.49 |
| Volume (last close) | 11.80K |
| Average Volume (3M) | 34.19K |
| Revenue (TTM) | 36.84M |
|---|---|
| Net Income (TTM) | -4.76M |
| Free Cash Flow (TTM) | -16.76M |
| EPS (TTM) | −$0.51 |
| Profit Margin | -12.91% |
| Operating Margin | -25.11% |
| Return on Equity (ROE) | -6.05% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 342.37M |
|---|---|
| Shares Outstanding | 12.41M |
| Price to Sales (P/S) | 9.29 |
| Price to Book (P/B) | 4.35 |
| EV/EBITDA | -35.19 |
| 50-Day MA | $31.79 |
|---|---|
| 200-Day MA | $34.27 |
| 1-Year Change | +36.38% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
vTv Therapeutics at a Glance
As of the Oct 16, 2026 close, vTv Therapeutics (VTVT) has a market capitalization of $342.37M. The stock trades at 9.3× sales. Over the trailing twelve months it lost $4.76M on revenue of $36.84M and burned $16.76M of free cash flow. Revenue grew 216600.0% year over year.
As of its latest reported balance sheet, it holds $86.64M in cash and securities against $0.00 of debt, a net cash position of $86.64M.
vTv Therapeutics does not currently pay a dividend.
The share price is up 36.4% over the past year. At $26.45 (the Oct 16, 2026 close) it sits within its 52-week range of $19.50 to $44.00, below its 200-day moving average of $34.27.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $56.80, 114.8% above the Oct 16, 2026 close.
Frequently Asked Questions About vTv Therapeutics
What is the current stock price for VTVT?
As of the Oct 16, 2026 close, VTVT stock trades at $26.45. The 52-week range is $19.50–$44.00, with a day range of $25.95–$27.49.
What is the P/E ratio for VTVT?
The P/E ratio (Price-to-Earnings) for VTVT is shown in the Key Statistics section. This valuation metric helps compare vTv Therapeutics Inc. to industry peers.
Does VTVT pay dividends?
vTv Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for VTVT?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for VTVT is Buy. The average 12-month price target is $56.80, a 114.8% upside from the Oct 16, 2026 close of $26.45.
What is the market cap of VTVT?
As of the Oct 16, 2026 close, vTv Therapeutics's market capitalization is $328.2M, classifying it as a small-cap company. vTv Therapeutics operates in the Healthcare sector within the Biotechnology industry.